| 0 |
VACCINATION SITE INDURATION |
1 |
0.0294 |
| 1 |
BILIRUBIN CONJUGATED ABNORMAL |
3 |
0.0270 |
| 2 |
VACCINATION SITE INFLAMMATION |
1 |
0.0175 |
| 3 |
VACCINATION SITE WARMTH |
1 |
0.0169 |
| 4 |
FOETAL CHROMOSOME ABNORMALITY |
1 |
0.0059 |
| 5 |
MECONIUM ASPIRATION SYNDROME |
1 |
0.0047 |
| 6 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 7 |
CHOLURIA |
1 |
0.0029 |
| 8 |
SKIN DISCHARGE |
1 |
0.0026 |
| 9 |
HYPOPROTEINAEMIA |
4 |
0.0021 |
| 10 |
TRANSAMINASES ABNORMAL |
1 |
0.0017 |
| 11 |
PERSISTENT FOETAL CIRCULATION |
1 |
0.0016 |
| 12 |
CELL DEATH |
3 |
0.0015 |
| 13 |
AORTIC DISORDER |
1 |
0.0013 |
| 14 |
BINGE EATING |
1 |
0.0009 |
| 15 |
HYPOVENTILATION |
3 |
0.0009 |
| 16 |
BLOOD CREATININE ABNORMAL |
3 |
0.0009 |
| 17 |
FANCONI SYNDROME |
1 |
0.0007 |
| 18 |
TONIC CONVULSION |
1 |
0.0007 |
| 19 |
IMPATIENCE |
1 |
0.0005 |
| 20 |
CHEST INJURY |
1 |
0.0005 |
| 21 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 22 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 23 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 24 |
HYPERCAPNIA |
1 |
0.0003 |
| 25 |
HEPATOMEGALY |
3 |
0.0003 |
| 26 |
PSYCHOMOTOR HYPERACTIVITY |
5 |
0.0003 |
| 27 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
| 28 |
SPONDYLITIS |
1 |
0.0003 |
| 29 |
JAUNDICE |
7 |
0.0003 |
| 30 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 31 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 32 |
HEPATITIS C |
3 |
0.0002 |
| 33 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6 |
0.0002 |
| 34 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 35 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 36 |
HEPATIC FAILURE |
6 |
0.0002 |
| 37 |
RENAL PAIN |
2 |
0.0002 |
| 38 |
NORMAL NEWBORN |
1 |
0.0002 |
| 39 |
CHOLESTASIS |
3 |
0.0002 |
| 40 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 41 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 42 |
ASCITES |
3 |
0.0001 |
| 43 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 44 |
INTENTIONAL SELF-INJURY |
2 |
0.0001 |
| 45 |
EATING DISORDER |
2 |
0.0001 |
| 46 |
NEOPLASM |
1 |
0.0001 |
| 47 |
SPINAL PAIN |
1 |
0.0001 |
| 48 |
NOCTURIA |
1 |
0.0001 |
| 49 |
POISONING |
1 |
0.0001 |
| 50 |
DISORIENTATION |
3 |
0.0001 |
| 51 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 52 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 53 |
EOSINOPHILIA |
1 |
0.0001 |
| 54 |
OEDEMA |
3 |
0.0001 |
| 55 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 56 |
INCREASED APPETITE |
1 |
0.0001 |
| 57 |
DYSPHONIA |
3 |
0.0001 |
| 58 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 59 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 60 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 61 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 62 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 63 |
SNEEZING |
1 |
0.0000 |
| 64 |
DRUG INTERACTION |
7 |
0.0000 |
| 65 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 66 |
HEPATITIS |
1 |
0.0000 |
| 67 |
EAR INFECTION |
1 |
0.0000 |
| 68 |
PALLOR |
1 |
0.0000 |
| 69 |
MOOD ALTERED |
1 |
0.0000 |
| 70 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 71 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 72 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 73 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 74 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 75 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 76 |
CHOLELITHIASIS |
1 |
0.0000 |
| 77 |
RENAL FAILURE |
4 |
0.0000 |
| 78 |
URINARY RETENTION |
1 |
0.0000 |
| 79 |
HYPOXIA |
1 |
0.0000 |
| 80 |
CRYING |
1 |
0.0000 |
| 81 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 82 |
PANIC ATTACK |
1 |
0.0000 |
| 83 |
RESTLESSNESS |
1 |
0.0000 |
| 84 |
CHILLS |
3 |
0.0000 |
| 85 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 86 |
DRUG ABUSE |
2 |
0.0000 |
| 87 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 88 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 89 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 90 |
RENAL DISORDER |
1 |
0.0000 |
| 91 |
COMA |
1 |
0.0000 |
| 92 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 93 |
PYREXIA |
7 |
0.0000 |
| 94 |
SOMNOLENCE |
4 |
0.0000 |
| 95 |
NERVOUSNESS |
1 |
0.0000 |
| 96 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 97 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 98 |
HYPONATRAEMIA |
1 |
0.0000 |
| 99 |
MYALGIA |
3 |
0.0000 |
| 100 |
SEIZURE |
2 |
0.0000 |
| 101 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 102 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 103 |
VERTIGO |
1 |
0.0000 |
| 104 |
ASTHENIA |
6 |
0.0000 |
| 105 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 106 |
SWELLING FACE |
1 |
0.0000 |
| 107 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 108 |
OVERDOSE |
3 |
0.0000 |
| 109 |
CONSTIPATION |
3 |
0.0000 |
| 110 |
AGITATION |
1 |
0.0000 |
| 111 |
EPISTAXIS |
1 |
0.0000 |
| 112 |
HALLUCINATION |
1 |
0.0000 |
| 113 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 114 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 115 |
ARTHRALGIA |
5 |
0.0000 |
| 116 |
BALANCE DISORDER |
1 |
0.0000 |
| 117 |
TACHYCARDIA |
1 |
0.0000 |
| 118 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 119 |
WEIGHT DECREASED |
3 |
0.0000 |
| 120 |
SINUSITIS |
1 |
0.0000 |
| 121 |
ILLNESS |
1 |
0.0000 |
| 122 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 123 |
HEADACHE |
6 |
0.0000 |
| 124 |
DIARRHOEA |
6 |
0.0000 |
| 125 |
INFLUENZA |
1 |
0.0000 |
| 126 |
WEIGHT INCREASED |
2 |
0.0000 |
| 127 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 128 |
PALPITATIONS |
1 |
0.0000 |
| 129 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 130 |
DIZZINESS |
4 |
0.0000 |
| 131 |
INSOMNIA |
2 |
0.0000 |
| 132 |
ANXIETY |
2 |
0.0000 |
| 133 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 134 |
VOMITING |
3 |
0.0000 |
| 135 |
TREMOR |
1 |
0.0000 |
| 136 |
FALL |
2 |
0.0000 |
| 137 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 138 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 139 |
ANAEMIA |
1 |
0.0000 |
| 140 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 141 |
PRURITUS |
2 |
0.0000 |
| 142 |
FEELING ABNORMAL |
1 |
0.0000 |
| 143 |
COUGH |
1 |
0.0000 |
| 144 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 145 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 146 |
PAIN |
2 |
0.0000 |
| 147 |
OFF LABEL USE |
2 |
0.0000 |
| 148 |
DYSPNOEA |
1 |
0.0000 |
| 149 |
FATIGUE |
1 |
0.0000 |
| 150 |
NAUSEA |
1 |
0.0000 |
| 151 |
DEATH |
1 |
0.0000 |
| 152 |
DRUG INEFFECTIVE |
1 |
0.0000 |